Indefinite Delivery Contract 75F40125D00003
- Not listed
- The Department of Health and Human Services Food and Drug Administration awarded an Indefinite Delivery Contract with a potential value of $25 million to Midnight Sun Technologies LLC. The contract is a single award, 8(a) sole source set aside for scientific support services to be performed across multiple locations including Silver Spring, MD, Vienna, VA, and Calverton, MD. The contract aims to procure subject matter expertise through various labor categories such as Scientist III, Researcher...
- The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery, indefinite quantity contract to Koniag Management Solutions LLC with a potential value of $25,000,000. Task orders issued against the contract procure scientific support services including research, laboratory analysis, and subject matter expertise to support the FDA's regulatory, compliance and public health programs. Task orders awarded to Koniag Management Solutions LLC and described in...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) to Research Triangle Institute (RTI International), a non-profit research organization, for the "Economic Studies of FDA Regulations" program. The $9,901,000 multiple-award IDC has a period of performance through September 14, 2024. Under this IDC, RTI has been issued several delivery orders, including: A $0 task order to develop an economic...
- The U.S. Food and Drug Administration (FDA) awarded a $1.1 million single-award indefinite delivery contract to Realm Research LLC, a minority-owned small disadvantaged business, to provide scientific and clinical support services related to monitoring the conduct and progress of extramural FDA-funded research studies in human subjects overseen by the Center for Drug Evaluation and Research (CDER). The contract, which was set aside for total small business participation, has an ultimate...
- The U.S. Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, awarded a $30 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business, for-profit organization, and limited liability company. The IDIQ contract, awarded in 2019 with a last ordering date of September 2024, enables the FDA to issue task orders to Spaulding for clinical and...
- The Federal Contract IDV award is a single-award Indefinite Delivery Contract valued at up to $3,446,837.42 for a period of performance from May 16, 2023 to May 16, 2026. The contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Syneos Health Research & Insights LLC. The contract aims to provide the FDA with access to healthcare practitioner prescribing practices data. The original solicitation was a combined synopsis/solicitation for commercial items,...
- The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to We Pharma, Inc., doing business as WEP Clinical, with a potential value of $9.5 million. The contract has no set-aside designation and is a single-award arrangement to provide currently marketed drug products for FDA research studies from September 2020 through September 2025. Under this contract, WEP Clinical has received multiple firm fixed price delivery orders to supply...
- The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to the National Academy of Sciences with a potential value of $30,000,000.00. The contract establishes a forum for the agency to convene committees for assessment, evaluations, and studies related to public health issues. Five task orders have been awarded against the contract to date, with periods of performance ranging from September 2022 through September 2025. Task orders...
- This indefinite delivery contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Research Triangle Institute (RTI International), a non-profit research organization, for ECONOMIC STUDIES OF FDA REGULATIONS. The single-award IDC has a ceiling value of $5,000,000.00 and a period of performance through September 19, 2029. Under this contract, RTI International will provide a range of technical and advisory services to support the FDA's regulatory and...
- This is a single-award Indefinite Delivery Contract (IDC) awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Metabolon, Inc., a small disadvantaged business. The contract has a ceiling value of $296,000.00 and a period of performance through August 1, 2030. The purpose of this IDC is to provide the FDA with indefinite delivery/indefinite quantity (IDIQ) services for metabolomic analysis of biological samples. Metabolon, as the prime contractor, will utilize its...
The Food and Drug Administration awarded a single-award Indefinite Delivery Contract valued at $50,000,000 to Tranquil Clinical and Research Consulting Services LLC (UEI: FWWJT8QCEDY4), effective September 15, 2025, through September 18, 2030. This contract, set aside for small businesses, supports the FDA's Office of Clinical Pharmacology through the provision of comprehensive clinical trial and laboratory support services. The contracted services encompass protocol development, clinical trial execution, bioanalytical testing, and ancillary laboratory studies designed to advance regulatory science and facilitate FDA review processes. The prime contractor must demonstrate capability to conduct multiple clinical trials simultaneously while maintaining full compliance with FDA regulations and International Council for Harmonisation Good Clinical Practice guidelines. Task orders issued under this indefinite delivery indefinite quantity vehicle are expected to range from one to five years in duration, with individual assignments varying in scope and complexity. The procurement was classified under NAICS code 541714 (Research and Development in Biotechnology) and PSC code AJ12 (General Science and Technology Research and Development Services), reflecting the specialized nature of the clinical and laboratory support required. This IDV structure enables the FDA to address clinical pharmacology needs and regulatory science objectives on an as-needed basis while maintaining a pre-established relationship with a qualified small business contractor capable of managing multiple concurrent clinical initiatives and maintaining rigorous compliance standards throughout service delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $0 | 10/20/25 |